Prevalent Practices of Thyroid Diseases During Pregnancy Among Endocrinologists, Internists and General Practitioners (original) (raw)

Abstract

Background: Maternal thyroid disease in pregnancy is associated with adverse impact on both mother and fetus. Both the American thyroid association and the endocrine society have recently published guidelines for the management of thyroid disease in pregnancy. Objectives: The objective of this survey was to assess and compare the current practices of various East-Asian physicians in the screening and management of thyroid disease in pregnancy. Materials and Methods: Completed survey questionnaires were collected from 112 physicians of six East-Asian countries. The survey was based on clinical case scenarios, asking questions about the clinical practices related to diagnosis and management of thyroid disease during pregnancy. Reponses from 76 endocrinologists and 33 internists and general practitioners (generalists) were analyzed. Results: There were minor differences in treatment preferences for Graves' disease in pregnancy and tests to monitor antithyroid drugs between endocrinologists and generalists; the major difference being targeted free thyroxin, and also thyroxin, depicted in the upper end of normal range, by the majority of endocrinologist and within the normal range, by generalists. Compared to generalists, endocrinologists perform more targeted screening and are more familiar with its risk factors. Predominantly, endocrinologists increase levothyroxine dose in hypothyroid women, upon confirmation of pregnancy and also indicate full dose in a pregnant woman, diagnosed with overt hypothyroidism, and treat thyroid peroxidase antibody positive or negative pregnant women with thyroid stimulating hormone (2.5-5 mU/L), as compared to generalists. Conclusions: There is wide variation in the clinical practices of screening and management of thyroid disorders during pregnancy in East-Asia, with many clinicians, in particular general practitioners, not adhering to clinical practice guidelines, unfortunately.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (39)

  1. Krassas GE, Poppe K, Glinoer D. Thyroid function and human re- productive health. Endocr Rev. 2010;31(5):702-55.
  2. Burman KD. Controversies surrounding pregnancy, maternal thyroid status, and fetal outcome. Thyroid. 2009;19(4):323-6.
  3. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21(10):1081-125.
  4. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Co- bin RH, et al. Management of thyroid dysfunction during preg- nancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(8):2543-65.
  5. Azizi F, Amouzegar A, Mehran L, Alamdari S, Subekti I, Vaidya B, et al. Screening and management of hypothyroidism in pregnan- cy: results of an Asian survey. Endocr J. 2014;61(7):697-704.
  6. Azizi F, Amouzegar A, Mehran L, Alamdari S, Subekti I, Vaidya B, et al. Management of hyperthyroidism during pregnancy in Asia. Endocr J. 2014;61(8):751-8.
  7. Vaidya B, Hubalewska-Dydejczyk A, Laurberg P, Negro R, Vermi- glio F, Poppe K. Treatment and screening of hypothyroidism in pregnancy: results of a European survey. Eur J Endocrinol. 2012;166(1):49-54.
  8. Azizi F, Amouzegar A. Management of hyperthyroidism during pregnancy and lactation. Eur J Endocrinol. 2011;164(6):871-6.
  9. Mestman JH. Hyperthyroidism in pregnancy. Clin Obstet Gynecol. 1997;40(1):45-64.
  10. Bahn RS, Burch HS, Cooper DS, Garber JR, Greenlee CM, Klein IL, et al. The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Adminis- tration. Thyroid. 2009;19(7):673-4.
  11. Clementi M, Di Gianantonio E, Cassina M, Leoncini E, Botto LD, Mastroiacovo P, et al. Treatment of hyperthyroidism in pregnan- cy and birth defects. J Clin Endocrinol Metab. 2010;95(11):E337-41.
  12. Ochoa-Maya MR, Frates MC, Lee-Parritz A, Seely EW. Resolu- tion of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves' hyperthyroidism. Thyroid. 1999;9(11):1111-4.
  13. Tan JY, Loh KC, Yeo GS, Chee YC. Transient hyperthyroidism of hy- peremesis gravidarum. BJOG. 2002;109(6):683-8.
  14. Mitsuda N, Tamaki H, Amino N, Hosono T, Miyai K, Tanizawa O. Risk factors for developmental disorders in infants born to wom- en with Graves disease. Obstet Gynecol. 1992;80(3 Pt 1):359-64.
  15. Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl. 2004;10(8):1018-23.
  16. Azizi F, Hedayati M. Thyroid function in breast-fed infants whose mothers take high doses of methimazole. J Endocrinol Invest. 2002;25(6):493-6.
  17. Azizi F, Bahrainian M, Khamseh ME, Khoshniat M. Intellectual de- velopment and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole. J Pediatr Endocrinol Metab. 2003;16(9):1239-43.
  18. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro- Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during preg- nancy. J Clin Endocrinol Metab. 2010;95(4):1699-707.
  19. Vaidya B, Anthony S, Bilous M, Shields B, Drury J, Hutchison S, et Int J Endocrinol Metab. 2016;14(1):e29601 al. Detection of thyroid dysfunction in early pregnancy: Univer- sal screening or targeted high-risk case finding? J Clin Endocrinol Metab. 2007;92(1):203-7.
  20. Horacek J, Spitalnikova S, Dlabalova B, Malirova E, Vizda J, Svilias I, et al. Universal screening detects two-times more thyroid dis- orders in early pregnancy than targeted high-risk case finding. Eur J Endocrinol. 2010;163(4):645-50.
  21. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Ga- gnon J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341(8):549-55.
  22. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005;105(2):239-45.
  23. Liu H, Momotani N, Noh JY, Ishikawa N, Takebe K, Ito K. Maternal hypothyroidism during early pregnancy and intellectual devel- opment of the progeny. Arch Intern Med. 1994;154(7):785-7.
  24. Lazarus JH, Bestwick JP, Channon S, Paradice R, Maina A, Rees R, et al. Antenatal thyroid screening and childhood cognitive func- tion. N Engl J Med. 2012;366(6):493-501.
  25. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Lars- en PR. Timing and magnitude of increases in levothyroxine re- quirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004;351(3):241-9.
  26. Mandel SJ, Larsen PR, Seely EW, Brent GA. Increased need for thy- roxine during pregnancy in women with primary hypothyroid- ism. N Engl J Med. 1990;323(2):91-6.
  27. Rotondi M, Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Amato G, et al. Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy. Eur J Endocrinol. 2004;151(6):695-700.
  28. Yassa L, Marqusee E, Fawcett R, Alexander EK. Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. J Clin Endocri- nol Metab. 2010;95(7):3234-41.
  29. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Cooma- rasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ. 2011;342:d2616.
  30. Iravani AT, Saeedi MM, Pakravesh J, Hamidi S, Abbasi M. Thyroid autoimmunity and recurrent spontaneous abortion in Iran: a case-control study. Endocr Pract. 2008;14(4):458-64.
  31. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complica- tions. J Clin Endocrinol Metab. 2006;91(7):2587-91.
  32. Moleti M, Trimarchi F, Vermiglio F. Doubts and Concerns about Isolated Maternal Hypothyroxinemia. J Thyroid Res. 2011;2011:463029.
  33. Casey BM, Dashe JS, Spong CY, McIntire DD, Leveno KJ, Cunning- ham GF. Perinatal significance of isolated maternal hypothyrox- inemia identified in the first half of pregnancy. Obstet Gynecol. 2007;109(5):1129-35.
  34. Henrichs J, Bongers-Schokking JJ, Schenk JJ, Ghassabian A, Schmidt HG, Visser TJ, et al. Maternal thyroid function dur- ing early pregnancy and cognitive functioning in early childhood: the generation R study. J Clin Endocrinol Metab. 2010;95(9):4227-34.
  35. Greenwald HP, Peterson ML, Garrison LP, Hart LG, Moscovice IS, Hall TL, et al. Interspecialty variation in office-based care. Med Care. 1984;22(1):14-29.
  36. Strauss MJ, Conrad D, LoGerfo JP, Hudson LD, Bergner M. Cost and outcome of care for patients with chronic obstructive lung dis- ease. Analysis by physician specialty. Med Care. 1986;24(10):915-24.
  37. Engel W, Freund DA, Stein JS, Fletcher RH. The treatment of pa- tients with asthma by specialists and generalists. Med Care. 1989;27(3):306-14.
  38. Greenfield S, Nelson EC, Zubkoff M, Manning W, Rogers W, Kravitz RL, et al. Variations in resource utilization among medical spe- cialties and systems of care. Results from the medical outcomes study. JAMA. 1992;267(12):1624-30.
  39. Greco PJ, Eisenberg JM. Changing physicians' practices. N Engl J Med. 1993;329(17):1271-3.